A multi-modal, physician-centered intervention to improve guideline-concordant prostate cancer imaging

以医生为中心的多模式干预措施,以改善符合指南的前列腺癌成像

基本信息

项目摘要

Background: Almost half of Veterans with localized prostate cancer (the most common non-cutaneous malignancy among US men) receive inappropriate, wasteful imaging. The VHA Blueprint for Excellence prioritizes increasing operational effectiveness. Prior studies seeking to limit inappropriate imaging did not assess barriers and achieved mixed results. Our team has explored the causes of guideline-discordant prostate cancer imaging and found that 1) patients with newly diagnosed prostate cancer have little concern for radiographic staging but rather focus on treatment, 2) physician trust imaging guidelines but are apt to follow their own intuition, fear medico-legal consequences, and succumb to influence from colleagues who image frequently. In spite of such discrepant v iews, most VHA physicians suggested or supported a large-scale effort to improve imaging use across VHA. Intervention: We propose a multi-site, stepped wedge, cluster-randomized trial to determine the effect of a physician-focused behavioral intervention on VHA prostate cancer imaging use. The multi-level intervention, developed according to the Theoretical Determinants Framework, combines traditional physician behavior change methods with novel methods of communication and data collection. The intervention consists of three components: 1) a system of audit and feedback to clinicians informing individual clinicians and their sites about how their behavior compares to their peers’ and to published guidelines 2) a program of academic detailing with the goal to educate providers about prostate cancer imaging, and 3) a CPRS Clinical Order Check for potentially inappropriate imaging. The intervention will be introduced to 10 participating geographically-distributed study sites. Analysis Plan: We will assess imaging rates 6 months prior to the intervention and 3 months following the intervention. The study’s specific aims seek to understand the effects of the intervention on 1) facility-level prostate cancer imaging rates, 2) physician experience with and perceptions of the intervention and its implementation, and 3) the costs of both implementing the intervention and affecting change in imaging use. These aims will support a subsequent intervention to improve guideline-concordant imaging across VHA. Experience gained through this project will be leveraged to improve guideline-concordant care and increase operational effectiveness in other domains. Importance: This project seeks to describe and analyze the implementation of a behavioral intervention to improve prostate cancer care. This theory-based intervention builds on prior work identifying barriers to guideline-concordant prostate cancer imaging in VHA (CDA 11-257) and addresses these at three levels: individual (audit and feedback with VHA Cancer Care Cube data), facility (academic detailing) and system (CPRS Order Check). The team will assess the intervention’s cost impact and providers’ experiences in preparation for a subsequent large -scale VHA implementation project optimizing the operational effectiveness of prostate cancer imaging across VHA. The current application is an opportunity to leverage VHA’s state-of-the-art, integrated healthcare delivery system to implement a carefully designed, theory-based behavioral intervention to reduce harmful, inappropriate care, increase appropriate care to those who truly need it, and simultaneously save money for the healthcare system.
背景:几乎一半的退伍军人患有局限性前列腺癌(最常见的非皮肤癌) 美国男性的恶性肿瘤)接受了不适当、浪费的成像。 VHA 卓越蓝图 优先考虑提高运营效率。先前寻求限制不当成像的研究并未评估 障碍并取得了好坏参半的结果。我们的团队探索了与指南不一致的前列腺癌的原因 影像学检查发现 1) 新诊断的前列腺癌患者很少关心放射线照相 分期,而是专注于治疗,2) 医生信任影像学指南,但倾向于遵循自己的直觉, 担心医疗法律后果,并屈服于经常成像的同事的影响。尽管 鉴于这种不同的观点,大多数 VHA 医生建议或支持大规模努力改善影像学的使用 穿过VHA。 干预:我们提出了一项多中心、阶梯式楔形、整群随机试验来确定干预措施的效果 针对 VHA 前列腺癌成像使用的以医生为中心的行为干预。多层次干预, 根据理论决定因素框架开发,结合​​传统医生行为 采用新颖的通信和数据收集方法来改变方法。干预措施包括三部分 组成部分: 1) 向临床医生提供审核和反馈的系统,告知各个临床医生及其站点有关 他们的行为与同龄人以及已发布的指南相比如何 2) 一个学术细节计划 目标是对提供者进行前列腺癌成像方面的教育,以及 3) 进行 CPRS 临床检查以发现潜在的问题 不适当的成像。该干预措施将引入 10 项参与的地理分布研究 网站。 分析计划:我们将评估干预前 6 个月和干预后 3 个月的成像率 干涉。该研究的具体目标旨在了解干预措施对 1) 设施层面的影响 前列腺癌成像率,2) 医生对干预措施及其实施的经验和看法 实施,以及 3) 实施干预措施和影响成像使用变化的成本。 这些目标将支持后续干预,以改善整个 VHA 的符合指南的成像。 通过该项目获得的经验将用于改善符合指南的护理并增加 其他领域的运营效率。 重要性:该项目旨在描述和分析行为干预的实施,以 改善前列腺癌护理。这种基于理论的干预措施建立在之前识别障碍的工作基础上 VHA (CDA 11-257) 中符合指南的前列腺癌成像并在三个层面上解决这些问题: 个人(使用 VHA Cancer Care Cube 数据进行审核和反馈)、设施(学术详细信息)和系统(CPRS 订单检查)。该团队将评估干预措施的成本影响和提供者的经验,为干预措施做好准备 随后的大规模VHA实施项目优化了前列腺癌的运营效率 跨 VHA 成像。当前的应用程序是一个利用 VHA 最先进的集成的机会 医疗保健服务系统实施精心设计的、基于理论的行为干预,以减少 有害的、不适当的护理,为真正需要的人增加适当的护理,同时节省金钱 对于医疗保健系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIL V. MAKAROV其他文献

DANIL V. MAKAROV的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIL V. MAKAROV', 18)}}的其他基金

Pragmatic Trial - Telehealth Research and Innovation for Veterans with Cancer (THRIVE).
务实试验 - 癌症退伍军人远程医疗研究和创新 (THRIVE)。
  • 批准号:
    10454678
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Pragmatic Trial - Telehealth Research and Innovation for Veterans with Cancer (THRIVE).
务实试验 - 癌症退伍军人远程医疗研究和创新 (THRIVE)。
  • 批准号:
    10684282
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Telehealth Research and Innovation for Veterans with Cancer (THRIVE)
患有癌症退伍军人的远程医疗研究和创新 (THRIVE)
  • 批准号:
    10454675
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Telehealth Research and Innovation for Veterans with Cancer (THRIVE)
患有癌症退伍军人的远程医疗研究和创新 (THRIVE)
  • 批准号:
    10684269
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
A multi-modal, physician-centered intervention to improve guideline-concordant prostate cancer imaging
以医生为中心的多模式干预措施,以改善符合指南的前列腺癌成像
  • 批准号:
    10186493
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Randomized trial of community health worker-led decision coaching to promote shared decision making for prostate cancer screening among Black male patients and their providers
社区卫生工作者主导的决策辅导随机试验,以促进黑人男性患者及其提供者在前列腺癌筛查方面的共同决策
  • 批准号:
    9768546
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
A multi-modal, physician-centered intervention to improve guideline-concordant prostate cancer imaging
以医生为中心的多模式干预措施,以改善符合指南的前列腺癌成像
  • 批准号:
    10308421
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Randomized trial of community health worker-led decision coaching to promote shared decision making for prostate cancer screening among Black male patients and their providers
社区卫生工作者主导的决策辅导随机试验,以促进黑人男性患者及其提供者在前列腺癌筛查方面的共同决策
  • 批准号:
    9890789
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Randomized trial of community health worker-led decision coaching to promote shared decision making for prostate cancer screening among Black male patients and their providers
社区卫生工作者主导的决策辅导随机试验,以促进黑人男性患者及其提供者在前列腺癌筛查方面的共同决策
  • 批准号:
    10372127
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Optimizing Imaging Use Among Veterans with Prostate Cancer
优化患有前列腺癌的退伍军人的成像使用
  • 批准号:
    8399138
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了